Preventive efficacy of a tenofovir alafenamide fumarate nanofluidic implant in SHIV-challenged nonhuman primates.

Saved in:
Bibliographic Details
Title: Preventive efficacy of a tenofovir alafenamide fumarate nanofluidic implant in SHIV-challenged nonhuman primates.
Authors: Pons-Faudoa FP; Department of Nanomedicine, Houston Methodist Research Institute, Houston, TX 77030, USA., Sizovs A; Department of Nanomedicine, Houston Methodist Research Institute, Houston, TX 77030, USA., Shelton KA; Department of Comparative Medicine, Michael E. Keeling Center for Comparative Medicine and Research, MD Anderson Cancer Center, Bastrop, TX 78602, USA., Momin Z; Department of Molecular Virology and Microbiology, Baylor College of Medicine, Houston, TX 77030, USA., Niles JA; Division of Infectious Diseases, Department of Internal Medicine, University of Texas Medical Branch (UTMB), Galveston, TX 77555, USA., Bushman LR; Deparment of Pharmaceutical Sciences, Skaggs School of Pharmacy and Pharmaceutical Sciences, University of Colorado- Anschutz Medical Campus, Aurora, CO 80045, USA., Xu J; Center for Outcomes Research and DeBakey Heart and Vascular Center, Houston Methodist Research Institute, Houston, TX 77030, USA., Chua CYX; Department of Nanomedicine, Houston Methodist Research Institute, Houston, TX 77030, USA., Nichols JE; Division of Infectious Diseases, Department of Internal Medicine, University of Texas Medical Branch (UTMB), Galveston, TX 77555, USA., Demaria S; Department of Radiation Oncology, Weill Cornell Medicine, New York, NY 10065, USA., Ittmann MM; Department of Pathology and Immunology, Baylor College of Medicine, Houston, TX 77030, USA., Hawkins T, Rooney JF; Gilead Sciences, Inc., Foster City, CA 94404, USA., Marzinke MA; Departments of Pathology and Medicine, Johns Hopkins University School of Medicine, Baltimore, MD 21224, USA., Kimata JT; Department of Molecular Virology and Microbiology, Baylor College of Medicine, Houston, TX 77030, USA., Anderson PL; Deparment of Pharmaceutical Sciences, Skaggs School of Pharmacy and Pharmaceutical Sciences, University of Colorado- Anschutz Medical Campus, Aurora, CO 80045, USA., Nehete PN; Department of Comparative Medicine, Michael E. Keeling Center for Comparative Medicine and Research, MD Anderson Cancer Center, Bastrop, TX 78602, USA., Arduino RC; Division of Infectious Diseases, Department of Internal Medicine, McGovern Medical School at The University of Texas Health Science Center, Houston, TX 77030, USA., Ferrari M; School of Pharmacy, University of Washington, Seattle, WA 98195, USA., Sastry KJ; Department of Comparative Medicine, Michael E. Keeling Center for Comparative Medicine and Research, MD Anderson Cancer Center, Bastrop, TX 78602, USA., Grattoni A; Department of Nanomedicine, Houston Methodist Research Institute, Houston, TX 77030, USA.
Source: Advanced therapeutics [Adv Ther (Weinh)] 2021 Mar; Vol. 4 (3). Date of Electronic Publication: 2020 Dec 16.
Publication Type: Journal Article
Journal Info: Publisher: WILEY-VCH Verlag GmbH & Co. KGaA Country of Publication: Germany NLM ID: 101724632 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2366-3987 (Electronic) Linking ISSN: 23663987 NLM ISO Abbreviation: Adv Ther (Weinh) Subsets: PubMed not MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:2366-3987
DOI:10.1002/adtp.202000163